Artificial Intelligence is revolutionizing drug discovery and biotechnology by enhancing speed, accuracy, and efficiency across the development pipeline. AI systems can rapidly analyze massive datasets, including genomic, proteomic, and chemical information, to identify potential drug candidates and predict their behavior within the human body. This significantly shortens the traditionally lengthy and costly process of drug development. AI also improves clinical trial design, patient selection, and outcome prediction, making trials more targeted and effective. In biotechnology, AI contributes to breakthroughs in areas such as protein engineering, vaccine development, and personalized medicine, enabling more precise and tailored therapeutic solutions. Overall, AI is driving innovation, reducing research costs, and accelerating the delivery of advanced healthcare solutions.
